StockData
Novo Nordisk A S logo

Novo Nordisk A S (NVO) stock

NVONYSEPharmaceutical PreparationsFiscal year ends December 31Also trades as NONOF
Financials through fiscal 2025, year ended Dec 31, 2025Score 4/30
$40.70−0.90 (-2.16%)

Close on Nov 17, 2026Market cap $181.73BP/E 12.0Yield –

Novo Nordisk A S ebitda

EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.

For fiscal 2025 it was 142.32B DKK, up 4.0% from the year before.

Annual ebitda

PeriodPeriod endValueChange
FY2025Dec 31, 2025142.32B DKK+4.0%
FY2024Dec 31, 2024136.88B DKK+24.6%
FY2023Dec 31, 2023109.86B DKK+35.0%
FY2022Dec 31, 202281.36B DKK–

More Novo Nordisk A S figures

See a number that looks wrong?